Caricamento...
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
AIMS: To evaluate efficacy and safety of RLY5016 (a non-absorbed, orally administered, potassium [K(+)]-binding polymer) on serum K(+) levels in patients with chronic heart failure (HF) receiving standard therapy and spironolactone. METHODS AND RESULTS: One hundred and five patients with HF and a hi...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069389/ https://ncbi.nlm.nih.gov/pubmed/21208974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehq502 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|